
Carbon-Negative Molecular Synthesis
Our platform translates cellular photosynthetic efficiency into high-purity bioactive compounds, capturing industrial carbon dioxide in a closed-loop system.
Thermodynamic Yield Efficiency
Traditional chemical synthesis relies on fossil feedstocks and high-energy thermal processes. Our platform bypasses these carbon-intensive pathways by utilizing engineered microalgae strains that directly convert industrial emissions into high-purity clinical compounds.
By optimizing cellular photosynthetic pathways, we operate with strict resource efficiency. The system requires ninety percent less water and land footprint than terrestrial crops, ensuring a scalable, secure supply chain for global partners.
Quantifiable Environmental Impact
1.8 kg
CO2 captured per kg of biomass
90%
Water footprint reduction
10x
Photosynthetic yield vs land crops
Accelerate Your Transition
Partner with Valgogenix to integrate certified carbon-negative compounds into your pharmaceutical pipeline and enterprise supply chain.
Valgogenix Biotech
Precision microalgae synthesis for pharmaceutical compounds and enterprise carbon capture.
Platform
Overview
About
Science
Pipeline
Sustainability
Careers
Inquiries
investors@valgogenix.com
Zurich, Switzerland
Clinical Facility: Basel
© 2026 Valgogenix Biotech-Clinical-grade synthesis platforms.
MOLECULAR PURITY - CARBON-NEGATIVE YIELD
